190 related articles for article (PubMed ID: 19186410)
1. Paralytics in critical care: not always the bad guy.
Forel JM; Roch A; Papazian L
Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410
[TBL] [Abstract][Full Text] [Related]
2. The role of neuromuscular blockers in ARDS: benefits and risks.
Hraiech S; Forel JM; Papazian L
Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
[TBL] [Abstract][Full Text] [Related]
3. The use of paralytics in patients with acute respiratory distress syndrome.
Hraiech S; Dizier S; Papazian L
Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
[TBL] [Abstract][Full Text] [Related]
4. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM
Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366
[TBL] [Abstract][Full Text] [Related]
5. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
Mefford B; Donaldson JC; Bissell BD
Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
[No Abstract] [Full Text] [Related]
6. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
[TBL] [Abstract][Full Text] [Related]
7. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
[TBL] [Abstract][Full Text] [Related]
8. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Lyu T; Lee YS; Dhanvijay S; Freebairn R
Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
[TBL] [Abstract][Full Text] [Related]
9. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
Hua Y; Ou X; Li Q; Zhu T
PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
[TBL] [Abstract][Full Text] [Related]
11. Early Paralysis for the Management of ARDS.
Grawe ES; Bennett S; Hurford WE
Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular blocking agents for acute respiratory distress syndrome.
Torbic H; Duggal A
J Crit Care; 2019 Feb; 49():179-184. PubMed ID: 30396789
[TBL] [Abstract][Full Text] [Related]
13. Effects of the use of neuromuscular blocking agents on acute respiratory distress syndrome outcomes: A systematic review.
Paramore S
J Am Assoc Nurse Pract; 2018 Jun; 30(6):327-332. PubMed ID: 29878965
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.
Tao W; Yang LQ; Gao J; Shao J
J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621
[TBL] [Abstract][Full Text] [Related]
15. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
Shao S; Kang H; Tong Z
BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
[TBL] [Abstract][Full Text] [Related]
16. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
[TBL] [Abstract][Full Text] [Related]
17. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome.
Arroliga AC; Thompson BT; Ancukiewicz M; Gonzales JP; Guntupalli KK; Park PK; Wiedemann HP; Anzueto A;
Crit Care Med; 2008 Apr; 36(4):1083-8. PubMed ID: 18401254
[TBL] [Abstract][Full Text] [Related]
18. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
[TBL] [Abstract][Full Text] [Related]
19. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
[TBL] [Abstract][Full Text] [Related]
20. A fresh look at paralytics in the critically ill: real promise and real concern.
Price D; Kenyon NJ; Stollenwerk N
Ann Intensive Care; 2012 Oct; 2(1):43. PubMed ID: 23062076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]